Better Therapeutics receives FDA authorisation for AspyreRx to treat adults with type 2 diabetes

10 July 2023 - In a randomised controlled trial AspyreRx demonstrated clinically meaningful and statistically significant durable reductions in A1c. ...

Read more →

Anumana receives US FDA breakthrough device designation for its cardiac amyloidosis algorithm

21 June 2023 - Developed in collaboration with Mayo Clinic, with support from Pfizer, this ECG-AI algorithm aims to aid ...

Read more →

Genetesis receives second FDA breakthrough device designation for non-invasive diagnosis of myocardial ischaemia using CardioFlux MCG

13 April 2023 - Designation represents progress for patients with suspected coronary microvascular dysfunction as the FDA recognises disease’s debilitating impacts ...

Read more →

Reach Neuro receives FDA breakthrough device designation for device to restore arm and hand movement to chronic stroke patients

10 April 2023 - Reach Neuro's Avantis device delivers small electrical impulses to the spinal cord to help stroke survivors ...

Read more →

FDA draft guidance allows AI/ML devices to evolve without requiring new submissions

31 March 2023 - The US FDA published a draft guidance outlining how sponsors of artificial intelligence and machine learning (AI/ML) ...

Read more →

Pixium Vision announces FDA breakthrough device designation for the Prima System in dry AMD

31 March 2023 - PRIMAvera European pivotal trial in dry AMD fully recruited and on track to report primary endpoints around ...

Read more →

FDA grants breakthrough device designation to Aural Analytics for speech analytics software to be used in treatment of ALS

29 March 2023 - Aural Analytics today announced that its Speech Vitals - ALS technology has been granted designation as ...

Read more →

Medical device companies now need to prove to FDA they’re protected against cyber attacks

29 March 2023 - Hidden in this year’s federal spending bill, among major changes to Medicare payments to doctors and ...

Read more →

The unique device identifier: a unique opportunity

7 March 2023 - A unique device identifier is an individualised alphanumeric signature associated with a single medical device. Since 2013, ...

Read more →

FDA grants Lenire tinnitus treatment device de novo approval

7 March 2023 - FDA approval based on results of 112 patient pivotal TENT-A3 clinical trial supported by confirmatory real world ...

Read more →

Sooma Medical receives FDA breakthrough device designation for its innovative at home depression treatment device

6 March 2023 - Sooma Medical has been granted breakthrough device designation by the US FDA for its portable, patient-administered ...

Read more →

Boomerang Medical earns FDA breakthrough device designation

1 March 2023 - Boomerang Medical is currently enrolling a clinical trial studying a bioelectronic device for people living with Crohn’s ...

Read more →

ONWARD receives new FDA breakthrough device designations for bladder control, alleviation of spasticity and blood pressure regulation after spinal cord injury

23 February 2023 - The company has now been awarded a total of eight FDA breakthrough device designations for its innovative ...

Read more →

Zephyrus Innovations announces US FDA approval for its Aeroject 3 mL safety syringe

16 February 2023 - Aeroject has a permanently attached needle system, which upon retraction, fully encases the needle, preventing needle reuse ...

Read more →

Merit Medical receives FDA breakthrough device designation for the new SCOUT MD surgical guidance system

16 February 2023 - Next generation system helps improve surgical precision to enhance patient care in breast and other soft tissue ...

Read more →